Document:

Exhibit 10.2

 

Execution Version

 

VOTING
AGREEMENT

 

This
VOTING AGREEMENT (this “Voting Agreement”) is made and entered into as of June 10, 2022 by and among Mobile
X Global Inc., a Delaware corporation (“Mobile X”), the undersigned shareholder (the “Shareholder”)
of Mobile X and Electro-Sensors, Inc., a Minnesota corporation (the “Parent”). Capitalized terms used but not
otherwise defined herein shall have the respective meanings ascribed to such terms in the Merger Agreement (as defined below).

 

RECITALS

 

A.          Concurrently
with the execution of this Voting Agreement, Mobile X, the Parent and Mobile X Newco, Inc., a Delaware corporation (“Merger
Sub”) are entering into an Agreement and Plan of Merger (as it may be amended, supplemented or otherwise modified from
time to time, the “Merger Agreement”) that provides, among other things, that the Merger Sub shall be merged
with and into Mobile X and Mobile X will continue as the surviving corporation and as a wholly owned subsidiary of the Parent,
in a transaction intended to qualify as a tax free reorganization under Sections 368(a)(1)(A) or 368(a)(2)(E) of the Internal
Revenue Code (the “Merger”).

 

B.           The
Shareholder is the owner of such number of outstanding shares of the MX Common Stock indicated on the final page of this Voting
Agreement and (if applicable) the Shareholder is also the owner of options to acquire such number of shares as is indicated on
the final page of this Voting Agreement.

 

C.           As
a material inducement to and condition precedent of Parent to enter into the Merger Agreement, Parent desires the Shareholder
to agree, and the Shareholder is willing to agree, to vote the Shares (as defined below) so as to facilitate consummation of the
Merger and to agree to the other matters set forth herein.

 

NOW,
THEREFORE, in consideration of the foregoing and the mutual promises, covenants and conditions set forth herein, the parties hereto
agree as follows:

 

		1.	Agreement
                                         to Vote Shares

 

1.1           Definitions. For the purposes of this Voting Agreement:

 

(a)           Shares.
The term “Shares” means such number of shares of capital stock of the Mobile X, including without limitation shares
of the MX Common Stock, owned of record or beneficially by the Shareholder or over which the Shareholder exercises voting power
as of the execution by the Shareholder of this Voting Agreement and all additional shares of capital stock of the Mobile X (including
all such additional shares, the “MX Common Stock”) of which the Shareholder acquires beneficial ownership or
voting power after the time that the Shareholder executes this Voting Agreement.

 

     

     

    

 

(b)          Transfer. The Shareholder shall be deemed to have effected a “Transfer” of a security if the Shareholder directly
or indirectly: (i) sells, pledges, encumbers, transfers or disposes of, or grants an option with respect to, such security
or any interest therein; or (ii) enters into an agreement or commitment providing for the sale, pledge, encumbrance, transfer
or disposition of, or grant of an option with respect to, such security or any interest therein.

 

(c)          Other.
The Shareholder is a “Company Stockholder” within the meaning of the Merger Agreement.

 

1.2          Agreement to Vote Shares. The Shareholder hereby irrevocably and unconditionally covenants and agrees that, at all times
prior to the termination of the Shareholder’s obligations under this Section 1.2 pursuant to Section 3 hereof, at any and
every meeting (whether annual or special and whether or not an adjourned or postponed meeting) of the shareholders of the Mobile
X, however called, and on any action or approval of the Mobile X’s shareholders by written consent, the Shareholder will
appear at the meeting or otherwise cause the Shares to be counted as present thereat for purposes of establishing a quorum and
vote (or cause to be voted, including via proxy), or with respect to any written consent, grant (or cause to be granted) such
consent as to, all of the Shares:

 

(a)          in favor of the approval and adoption of the Merger Agreement and the Merger, the Transactions and the other actions contemplated
by or in furtherance of the Merger Agreement; and

 

(b)          against any action or proposal that could reasonably be expected to adversely affect Parent’s rights and benefits under
the Merger Agreement.

 

The
obligations of the Shareholder specified in this Section 1.2 shall (i) apply whether or not the Merger or any action described
above is recommended by the Mobile X’s board of directors or committee thereof but (ii) shall cease to apply after the termination
of Shareholder’s obligations under this Section 1.2 pursuant to Section 3 hereof. The Shareholder shall execute and deliver
(or cause the holders of record to execute and deliver), and shall use commercially reasonable efforts to do the same within 48
hours of receipt thereof, any proxy card or voting instructions it receives that is sent to shareholder of the Mobile X soliciting
proxies with respect to the proposals described in clauses (a), (b) and (c) of this Section 1.2 (the “Covered Proposals”),
which shall be voted in the manner described in Section 1.2. This Voting Agreement is intended to bind the Shareholder as a shareholder
of the Mobile X (and not in any other capacity such as a director or officer of the Mobile X or any of its Affiliates) and only
with respect to the Covered Proposals. Except as provided for in this Section 1.2, the Shareholder shall not be restricted from
voting in favor of, against or abstaining with respect to any other matter presented to the shareholders of the Mobile X. The
Shareholder further agrees not to enter into any agreement or understanding with any person that would be inconsistent with or
violate any provision in this Section 1.2. Notwithstanding any other provision in this Voting Agreement to the contrary,
in no event shall this Voting Agreement constitute an acknowledgement by Parent or Shareholder that the execution and delivery
by Parent or the Shareholder of this Voting Agreement results in Parent acquiring beneficial ownership of any of the Shares.

 

     2

     

    

 

1.3          Transfer and Other Restrictions.

 

(a)          Prior to the termination of the Shareholder’s obligations under this Section 1.3 pursuant to Section 3 hereof, the Shareholder
agrees not to, directly or indirectly (with any Transfer, attempted Transfer or action in violation of this Section 1.3(a) being
null and void and of no effect whatsoever):

 

(i)           offer for sale, Transfer or otherwise dispose of, or enter into any contract, option or other arrangement or understanding with
respect to, or consent to the offer for sale, Transfer or other disposition of, any or all of the Shares or any interest therein
except as provided in Section 1.5(a) below;

 

(ii)          grant any proxy or power of attorney with respect to the Shares, deposit any of the Shares into a voting trust or enter into a
voting agreement or arrangement with respect to the Shares other than in connection with this Voting Agreement; or

 

(iii)         take any other action that would make any representation or warranty of the Shareholder contained herein untrue or incorrect or
have the effect of preventing or disabling the Shareholder from performing his or its obligations under this Voting Agreement.

 

(b)          Notwithstanding anything in this Voting Agreement to the contrary, the Shareholder may Transfer all or a portion of the Shares
to (i) any other Person who enters into a voting agreement (or similar Contract) with Parent on substantially similar terms and
conditions as set forth in this Voting Agreement or to any Affiliate of such Person, (ii) any immediate family member (including
a trust for such family member’s benefit) of the Shareholder, (iii) if the Shareholder is an entity, any shareholder, member
or partner of the Shareholder, (iv) any Person if and to the extent required by any order or decree by a Governmental Authority
(including by divorce decree), or by will, intestacy or other similar Law or (v) any charitable foundation or organization, in
each case, only so long as, prior to and as a condition to effectuating any such Transfer, the assignee or transferee agrees to
be bound by the terms of this Voting Agreement and first executes and delivers to the parties hereto a written consent and joinder
memorializing such agreement in form and substance reasonably satisfactory to Mobile X and Parent. During the term of this Voting
Agreement, the Mobile X will not register or otherwise recognize the transfer (book-entry or otherwise) of any Shares or any certificate
or uncertificated interest representing any of the Shares, except as permitted by, and in accordance with, this Section 1.3(b),
receipt of written consent by the parties or as, in the reasonable determination of the Mobile X, required by law.

 

(c)          To the extent the Shareholder is, as of the date hereof, party to a contract or agreement that requires the Shareholder to Transfer
Shares to another person or entity, the Shareholder will not effect any such Transfer unless and until the transferee agrees to
be bound by and executes an agreement in the form of this Voting Agreement with respect to the Shares to be Transferred. Nothing
herein shall prohibit the Shareholder from exercising any option the Shareholder may hold in accordance with the terms of the
option, provided that the securities acquired upon the exercise will become subject to this Voting Agreement.

 

     3

     

    

 

1.4          Waivers of Certain Rights and Actions. Shareholder hereby agrees not to commence or participate in, and to take all actions
necessary to opt out of any class in any class action with respect to, any Action, derivative or otherwise, against the Parent,
Mobile X, or any of their respective Subsidiaries or successors: (a) challenging the validity of, or seeking to enjoin or delay
the operation of, any provision of this Agreement or the Merger Agreement (including any claim seeking to enjoin or delay the
Closing); or (b) to the fullest extent permitted under Law, alleging a breach of any duty of the Board of Directors of the Parent
or Mobile X in connection with the Merger Agreement, this Agreement, or the transactions contemplated thereby or hereby.

 

1.5          Other Agreements.

 

(a)          Upon the request of Parent, the Shareholder agrees to notify promptly Parent of the number of any additional shares of the MX
Common Stock acquired by the Shareholder, if any, after the execution of this Voting Agreement.

 

(b)          The Shareholder agrees that any shares of MX Common Stock that the Shareholder purchases or with respect to which the Shareholder
otherwise acquires record or beneficial ownership (including (i) any shares of MX Common Stock that the Shareholder acquires pursuant
to the exercise or settlement of any Company Stock Options (but excluding shares of MX Common Stock underlying unexercised Company
Stock Options (until such time as any such Company Stock Options are exercised and the underlying shares of MX Common Stock are
acquired by the Shareholder)) or (ii) pursuant to a stock split, reverse stock split, stock dividend or distribution or any change
in MX Common Stock by reason of any recapitalization, reorganization, combination, reclassification, exchange of shares or similar
transaction) after the date hereof and prior to (and until) the termination of this Agreement in accordance with Section 3, shall
automatically become, and shall be deemed to be, Shares and will thereafter be subject to the terms and conditions of this Agreement
to the same extent as if they comprised Shares on the date hereof.

 

(c)          The Shareholder further agrees that, from and after the date hereof until the termination of this Voting Agreement in accordance
with Section 3, the Shareholder will not, and will not cause any entity under the Shareholder’s control to, (i) solicit
proxies or become a “participant” in a “solicitation” (as such terms are defined in Rule 14A under the
Exchange Act) in opposition to any Covered Proposal, or (ii) take any action that the Mobile X is prohibited from taking pursuant
to the Merger Agreement, subject in each case to Shareholder’s right (but without affecting Shareholder’s obligations
under this Voting Agreement in Shareholder’s capacity as a Shareholder) to act in his or her capacity as a director or officer
of the Mobile X and comply with his or her fiduciary duties or other legal obligations or responsibilities while acting in such
capacity as a director or officer of the Mobile X.

 

(d)          Shareholder agrees that during the term of this Voting Agreement Shareholder will not, and will not permit any entity under Shareholder's
control to, deposit any of the Shares in a voting trust, grant any proxies with respect to the Shares, or subject any of the Shares
to any arrangement with respect to the voting of the Shares other than agreements entered into with Mobile X.

 

     4

     

    

 

1.6           Proxy. Solely in the event of a failure by the Shareholder to act in accordance with such Shareholder’s obligations
as to voting pursuant to Section 1.2, such Shareholder hereby irrevocably grants to and appoints Parent (and any designee thereof)
as such Shareholder’s proxy and attorney-in-fact (with full power of substitution), for and in the name, place and stead
of the Shareholder, to represent, vote and otherwise act (by voting at any meeting of shareholders of the Mobile X or otherwise)
with respect to such Shareholder’s Shares solely as and to the extent set forth in this Section 1.6 until the termination
of this Voting Agreement in accordance with its provisions, to the same extent and with the same effect as the Shareholder might
or could do under applicable law, rules and regulations. The proxy granted pursuant to this Section 1.6 is coupled with an interest
and is irrevocable. The Shareholder will take such further action and will execute such other instruments as may be necessary
to effectuate the grant of this proxy. The power of attorney granted by Shareholder herein (if Shareholder is a natural person)
is a durable power of attorney and shall survive the bankruptcy, death or incapacity of such Shareholder. Notwithstanding the
foregoing, this proxy shall terminate upon termination of this Voting Agreement in accordance with Section 3.

 

		2.	Representations
                                         and Warranties of the Shareholder

 

2.1           Ownership. The Shareholder is the record and beneficial owner of, and the Shareholder exercises exclusive voting power
over, the number of shares of the MX Common Stock indicated on the final page of this Voting Agreement, which are free and clear
of any Encumbrances (other than those created by this Agreement and those arising under applicable United States securities laws),
proxy, voting restriction or adverse claim. The number of shares of MX Common Stock set forth on the final page hereto are the
only shares of capital stock of the Mobile X owned of record or beneficially by the Shareholder and, except as set forth on such
page, the Shareholder holds no options to purchase or rights to subscribe for or otherwise acquire any securities of the Mobile
X and has no other interest in or voting rights with respect to any securities of the Mobile X.

 

2.2           Power and Authority; No Conflict. The Shareholder has the requisite power and authority (or, if a natural person, the requisite
power and capacity) to enter into this Voting Agreement and to consummate the transactions contemplated by this Voting Agreement.
The execution and delivery of this Voting Agreement by the Shareholder and the consummation by the Shareholder of the transactions
contemplated by this Voting Agreement have been duly authorized by all necessary action. This Voting Agreement has been duly executed
and delivered by the Shareholder and constitutes a valid and binding obligation of the Shareholder, enforceable against the Shareholder
in accordance with its terms, except (i) as the same may be limited by applicable bankruptcy, insolvency, moratorium or similar
laws of general application relating to or affecting creditors’ rights, and (ii) for the limitations imposed by general
principles of equity. The execution and delivery of this Voting Agreement does not, and the consummation of the transactions contemplated
by this Voting Agreement and compliance with the provisions of this Voting Agreement will not, conflict with, or result in any
violation of or default (with or without notice or lapse of time, or both) under, or give rise to a right of termination, cancellation
or acceleration of any obligation that would result in the creation of any Encumbrance upon any of the Shares owned by the Shareholder
under, any provision of applicable law or regulation or of any agreement, judgment, injunction, order, decree or other instrument
binding on the Shareholder or any Shares owned by the Shareholder. The execution and delivery of this Voting

 

     5

     

    

 

Agreement by the
Shareholder do not, and the performance of this Voting Agreement by the Shareholder will not, require any written, oral or other
agreement, contract or legally binding commitment of any third party. If this Voting Agreement is being executed in a representative
or fiduciary capacity, the person signing this Voting Agreement has full power and authority to enter into and perform this Voting
Agreement. No consent, approval, order or authorization of, or registration, declaration or, except as required by the rules and
regulations promulgated under the Exchange Act, filing with, any Governmental Authority or any other Person, is required by or
with respect to the Shareholder in connection with the execution and delivery of this Voting Agreement or the consummation by
them of the transactions contemplated hereby. As of the date hereof, there is no legal action pending against, or, to the knowledge
of the Shareholder, threatened against or affecting the Shareholder that would reasonably be expected to materially impair the
ability of the Shareholder to perform its obligations hereunder or to consummate the transactions contemplated hereby on a timely
basis.

 

		3.	Termination
                                         Of Obligations

 

The
obligations of the Shareholder pursuant to Sections 1.2, 1.3 and 1.5 hereof shall terminate upon the earliest of (i) the
Effective Time and (ii) the date and time of the termination of the Merger Agreement pursuant to Article IX thereof; provided
that the provisions of Section 4 shall survive any such termination. Notwithstanding the foregoing, termination of this Voting
Agreement shall not prevent any party from seeking any remedies (at law or in equity) against any other party for that party’s
breach of any of the terms of this Voting Agreement prior to the date of termination in accordance with Section 3. In addition,
this Voting Agreement may be terminated in its entirety by Parent by providing written notice of such termination to Mobile X
and the Shareholder, and such termination shall be effective immediately upon delivery of such notice.

 

		4.	Miscellaneous

 

4.1           Severability. If any term, provision, covenant or restriction of this Voting Agreement is held by a court of competent
jurisdiction to be invalid, void or unenforceable, then the remainder of the terms, provisions, covenants and restrictions of
this Voting Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated.

 

4.2           Binding Effect and Assignment. This Voting Agreement and all of the provisions hereof shall be binding upon and inure to
the benefit of the parties hereto and their respective successors and permitted assigns, but, except as otherwise specifically
provided herein, neither this Voting Agreement nor any of the rights, interests or obligations of the parties hereto may be assigned
by either of the parties without prior written consent of the other. Any purported assignment in violation of this Section 4.2
shall be void.

 

4.3           Amendments and Modification. This Voting Agreement may not be modified, amended, altered or supplemented except upon the
execution and delivery of a written agreement executed by the parties hereto.

 

4.4           Notices. All notices and other communications hereunder shall be in writing and shall be deemed duly given upon delivery
either by commercial delivery service, or

 

     6

     

    

 

sent via facsimile (receipt confirmed), to the parties at the following address or facsimile
numbers (or at such other address or facsimile numbers for a party as shall be specified by like notice):

 

If
to Mobile X or any Shareholder:

 

Mobile
X Global, Inc. 

Attention:
Peter Adderton, Chief Executive Officer; Justin O’Neill, General Counsel

12 Sail Vista 

Newport
Coast, CA 92657 

Email:

 

with
a copy to:

 

Proskauer
Rose LLP 

Attention:
Ben D. Orlanski 

2029
Century Park East, Suite 240 

Los
Angeles, CA 90067 

Email: 

 

If
to the Parent, to Electro-Sensors, Inc., c/o Ballard Spahr LLP, 2000 IDS Center, 80 South Eighth Street, Minneapolis, MN 55402,
Attention: George H. Singer, Email: 

 

Any
party hereto may by notice so given provide and change its address for future notices hereunder. Notice shall conclusively be
deemed to have been given when personally delivered or when deposited in the mail in the manner set forth above.

 

4.5           Governing Law; Disputes; Submission to Jurisdiction; Waiver of Jury Trial. This Voting Agreement shall be governed by and
construed exclusively in accordance with the laws of the State of Minnesota, except that the General Corporation Law of the State
of Delaware and the case law interpreting such law shall govern all aspects of this Voting Agreement that are essentially part
of, derive from or are dependent upon the internal affairs of Mobile X. Each of the parties to this Voting Agreement (a) consents
to submit itself to the exclusive personal jurisdiction of the state courts of the State of Minnesota or, to the extent such court
does not have subject matter jurisdiction, the United States District Court for the District of Minnesota (as applicable, the
“Chosen Court”) in any action or proceeding arising out of or relating to this Voting Agreement or any of the Transactions,
(b) agrees that all claims in respect of such action or proceeding shall be heard and determined in any such Chosen Court, (c)
agrees that it shall not attempt to deny or defeat such personal jurisdiction by motion or other request for leave from any such
Chosen Court and (d) agrees not to bring any action or proceeding arising out of or relating to this Voting Agreement or any of
the transaction contemplated by this Voting Agreement in any other court. Each of the parties hereto waives any defense of inconvenient
forum to the maintenance of any action or proceeding so brought and waives any bond, surety or other security that might be required
of any other party with respect thereto. Any party may make service on another party by sending or delivering a copy of the process
to the

 

     7

     

    

 

party to be served at the address and in the manner provided for the giving of notices in Section 4.4. Nothing in this
Section 4.5, however, shall affect the right of any party to serve legal process in any other manner permitted by law. EACH OF
SHAREHOLDER, PARENT AND MOBILE X HEREBY IRREVOCABLY WAIVES ALL RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING OR COUNTERCLAIM
(WHETHER BASED ON CONTRACT, TORT OR OTHERWISE) ARISING OUT OF OR RELATING TO THIS VOTING AGREEMENT OR THE TRANSACTIONS OR THE
ACTIONS OF SHAREHOLDER, PARENT OR MOBILE X IN THE NEGOTIATION, ADMINISTRATION, PERFORMANCE AND ENFORCEMENT OF THIS VOTING AGREEMENT.

 

4.6           Publicity. The Shareholder acknowledges and represents that it supports the Merger pursuant to the terms of the Merger
Agreement and authorizes each of the Parent and Mobile X to make a general statement to that effect (including Shareholder’s
identity and holding of Shares and the related obligations of Shareholder hereunder) in press releases and public filings that
may be made with the SEC, Nasdaq or other regulatory authorities.

 

4.7           Specific Performance. The parties hereto agree that irreparable damage would occur in the event that any of the provisions
of this Agreement was not performed in accordance with its specific terms or was otherwise breached. It is accordingly agreed
that the parties shall be entitled to an injunction or injunctions to prevent breaches of this Agreement and to enforce specifically
the terms and provisions hereof in any Minnesota court, without proof of damages, prior to the valid termination of this Voting
Agreement, this being in addition to any other remedy to which they are entitled under this Voting Agreement, and (b) the
right of specific enforcement is an integral part of the transactions contemplated by this Voting Agreement and without that right,
none of the parties would have entered into this Voting Agreement. Each party agrees that it will not oppose the granting of specific
performance and other equitable relief on the basis that the other parties have an adequate remedy at Law or that an award of
specific performance is not an appropriate remedy for any reason at Law or equity. The parties acknowledge and agree that any
party seeking an injunction to prevent breaches of this Voting Agreement and to enforce specifically the terms and provisions
of this voting Agreement in accordance with this Section 4.7 shall not be required to provide any bond or other security
in connection with any such injunction.

 

4.8           Entire Agreement. This Voting Agreement constitutes and contains the entire agreement and understanding of the parties
with respect to the subject matter hereof and supersedes any and all prior negotiations, correspondence, agreements, understandings,
duties or obligations between the parties respecting the subject matter hereof.

 

4.9           Counterparts. This Voting Agreement may be executed in facsimile, pdf or other electronic means and in or more counterparts,
each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

 

4.10         Further Assurances. Shareholder agrees, from time to time, and without additional consideration, to execute and deliver
such additional proxies, documents, and other instruments and to take all such further action as the Parent and Mobile X may reasonably
request to consummate and make effective the transactions contemplated by this Voting Agreement.

 

     8

     

    

 

4.11         No Agreement Until Executed. Irrespective of negotiations among the parties or the exchanging of drafts of this Voting
Agreement, this Voting Agreement shall not constitute or be deemed to evidence a contract, agreement, arrangement or understanding
between the parties unless and until (a) the Mobile X Board of Directors has approved, for purposes of any applicable provision
of the Mobile X’s organizational and governance documents, the transactions contemplated by the Merger Agreement (including
the Merger), (b) the Merger Agreement is executed by all parties thereto, and (c) this Voting Agreement is executed by all parties
hereto.

 

4.12         Captions. The captions to sections of this Voting Agreement have been inserted for identification and reference purposes
only and shall not be used to construe or interpret this Voting Agreement.

 

     9

     

    

 

In
Witness Whereof, the parties hereto have caused
this Voting Agreement to be executed by their duly authorized respective officers as of the date first above written. 

 

	 	MOBILE X GLOBAL, INC.
	 	 
	 	By:	 /s/
    Dan Cohrs

	 	Name:	 Dan Cohrs

	 	Title:	 Chief
    Financial Officer

 

	 	ELECTRO-SENSORS, INC.
	 	 
	 	By:	/s/ David L. Klenk

	 	Name:	 David
    L. Klenk

	 	Title:	 Chief
    Financial Officer

 

	 	THE SHAREHOLDER:

 

	 	Signature:	 /s/
    Signed by Shareholders on Schedule 1-B 

 

	 	Printed Name:	 

 

	 	the Shareholder’s
    Address for Notice:
	 	 
	 	 
	 	 

 

	 	Outstanding
    Shares of the Mobile X Common
	 	Stock Beneficially
    Owned by the
	 	Shareholder:_________
	 	 
	 	Outstanding Options
    to Acquire Shares of Mobile X Common Stock Owned by the Shareholder:________

 

    10

     

    

 

	Schedule 1-B to Company  Voting
    Agreement
	 	 	 
	Equity
	Investor	Common
    Shares
	Peter Adderton	3,000.00
	Stuart Bird	713.33
	Peter Hill	777.00
	Dan Cohrs	356.67agtx_ex101.htm

 
 EXHIBIT 10.1
  
  
 AGENTIX Corp.
 CONSULTING AGREEMENT
  
 THIS CONLSULTING AGREEMENT (this “Agreement”) is made and entered into as of October 1, 2020 (the “Effective Date”) by and between AGENTIX Biopharma Corp. (“AGENTIX”) corporation (the “Company”) and SALMAN HODA PHARMA CONSULTING INC, a corporation registered in the Province of Ontario, Canada located at _____________________ (the “Consultant”).
  
 WHEREAS, the Consultant is an advisor to the Company, and Company desires to retain Consultant as an independent contractor to provide certain services to the Company during the Consulting Period (as hereinafter defined); 
  
 WHEREAS, the Consultant desires to finalize a formal Agreement with the Company in accordance with the terms hereof; and
  
 WHEREAS, the Company and the Consultant mutually intend to set forth herein the terms and conditions of the Consultant’s provision of services on an independent contracting basis during the Consulting Period.
  
 NOW, THEREFORE, in consideration of the mutual covenants contained herein, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Company and Consultant agree as follows:
  
 1. Independent Contracting. 
  
 (a) Independent Contracting. Consultant will provide certain services to the Company as set forth on Schedule A attached hereto, which services will be provided to the Company on an independent contracting basis, from and after the Effective Date through December 31, 2022 (the “Consulting Period”). During the Consulting Period, the relationship between the Company and the Consultant shall not constitute an employer/employee relationship, partnership, joint venture, or agency of any kind, and neither party shall have the authority to act for or on behalf of the other.
  
 (b) Consulting Conditions. During the Consulting Period, the Consultant shall serve, at the discretion of the Chief Executive Officer (“CEO”). The Consultant’s duties hereunder will be those normally incident to the positions of SVP of Portfolio and Business Development, and such other duties as may be reasonably assigned to him from time to time by the CEO. During the Consulting Period, except for illness and vacation periods, the Consultant shall devote a majority of his business time, attention, skill and efforts to the faithful performance of his duties hereunder. The Consultant shall not be involved with any activities and/or investments that impair the ability of the Consultant to perform the duties of his position faithfully and to his best ability.
  
  
 	 
	
	

	 

 
 
  
 2. Term / Termination.
  
  
 	 (a)
	 Term.  This Agreement shall automatically renew for additional one (1) year terms at the expiration of the Consulting Period or any applicable renewal term, unless the Company or the Consultant provides the other party notice of its or his intent not to renew this Agreement not less than ninety (90) days prior to the end of the Employment Term or any applicable renewal term.  

	  
	  

	 (b)
	 Termination for Cause. During the Consulting Period, The Consultant's engagement may be terminated by the Company for “Cause.” For purposes of this Agreement, “Cause” shall mean (i) the Consultant's conviction, or pleading guilty or nolo contendere to, a felony or other crime involving moral turpitude, (ii) the Consultant’s engagement, having a material adverse impact on the Company and its activity, in fraud, dishonesty, embezzlement, insubordination, gross negligence or gross misconduct, (iii) the failure of the Consultant to perform his assigned duties or follow the reasonable and lawful directives of the CEO, which failure is not cured within fifteen (15) days of written notice from the Company of such material failure, (iv) the material breach by the Consultant of his obligations hereunder or under any material provision of the Company’s Code of Conduct or any related agreements with the Company, which breach (to the extent curable) is not cured within fifteen (15) days of written notice from the Company of such breach, or (v) any of the causes described in the applicable Labor Code. The Consultant shall not be deemed to have been terminated for Cause unless and until there shall have been delivered to him written notice of such termination.

	  
	  

	 (c)
	 Termination by Consultant for Good Reason. The Consultant's employment may be terminated by the Consultant upon not less than thirty (30) days' prior written notice given to the Company within thirty (30) days after the occurrence of any of the following events:

 
 
  
 (i) a material diminution by the Company of the responsibility, importance or scope of the Consultant’s functions, duties or position with the Company from the position and attributes thereof described in Section 1 that is not cured within twenty (20) days of written notice from Consultant of such breach;
  
 (ii) a relocation of the Consultant to a site more than one hundred (100) miles from the extant Consultant work site at the time of the Effective Date;
  
 (iii) breach by the Company of any material provision hereof (with all defaults in payments of money due under Section 3 and Schedule A hereunder being deemed material), which breach (to the extent curable) is not cured within thirty (30) days of written notice from Consultant of such breach to the CEO and/or the Chairperson of the Board of Directors; or
  
 (iv) a reduction of twenty percent (20%) or more in the Consultant’s Compensation (as defined in Section 3 below).
  
 (v) Change of Control, as defined in Section 5 hereinbelow and written notice by the Consultant to the Company of his election to terminate his employment therefor delivered not less than thirty (30) days prior to the date of termination and not more than One Hundred Eighty (180) days after the Change of Control; or
  
  
 	 
	2
	

	 

 
 
  
 (vi) a material breach by other Officers and/or the Board of Directors of governing Company documents (e.g., Articles of Incorporation, By-Laws, etc.), laws, or government regulations causing material harm to Consultant’s ability to achieve Company objectives.
  
 All written notices described in this Section 2(c) shall set forth in reasonable detail the facts and circumstances claimed by Consultant as basis for a Good Reason termination.
  
  
 	 (d)
	 Termination by Reason of Death or Disability. The Consultant's engagement will automatically terminate upon the death or Disability of the Consultant. For purposes of this Section 2(d), the term “Disability” shall mean the inability or failure of the Consultant to perform the essential functions of his position with the Company with or without reasonable accommodation as a result of a mental or physical disability for a total of forty-five (45) consecutive days or ninety (90) or more days (whether or not consecutive) during any consecutive twelve (12) months, all as determined in good faith by a majority of the members of the Board of Directors; provided, however, if the Company maintains a policy insuring against the disability of Consultant, then “Disability” shall have the same meaning as in such policy.

	  
	  

	 (e)
	 Termination by Company without Cause. The Consultant’s engagement may be terminated by the Company without Cause, at any time, for any reason or for no reason, upon thirty (30) days’ prior written notice of termination and the payment of all indemnities according to the applicable legislation and Section 3 hereunder. 

	  
	  

	 (f)
	 Termination by Consultant without Good Reason. The Consultant's engagement may be terminated by the Consultant without Good Reason, at any time, upon thirty (30) days’ prior written notice of termination. Upon receipt of the Consultant’s written notice of termination, the Company may immediately terminate the Consultant’s engagement upon the payment of all indemnities according to the applicable legislation and Section 3 hereunder.

	  
	  

	 3.
	 Effect of Termination.

	  
	  

	 (a)
	 Subject to the terms of this Section 3, all rights of the Consultant under this Agreement shall terminate upon the effective date of termination (the “Termination Date”); provided, however, that the Consultant shall be entitled to the Base Salary that has accrued and is unpaid through the Termination Date, less any required withholdings, which shall be paid no later than the next regular payroll date after the Termination Date, as well as any Incentive Stock Options as defined in and pursuant to Section  5 hereinbelow.  If, however, the Company terminates the Consultant without cause pursuant to Section 2(e) or the Consultant terminates for Good Reason under Section 2(c) hereof, then, in addition to these amounts, the Company shall pay the Consultant, for a period equal to thirty (30) days after the Termination Date, in accordance with Company payroll practices in effect from time to time, his Base Salary. The Company shall also provide all of the Consultant's accrued benefits up to the Termination Date; and continue to provide health plan benefits, if any, through the end of the severance period.

 
 
 
  
 
   
  	 
	3
	

	 

 
   
  
If the Consultant’s engagement is terminated by the Company for Cause, or by the Consultant other than for Good Reason, then, in any of such events, the Company shall have no obligation to make any payments to the Consultant for any period subsequent to such termination, except as provided otherwise by the law, except that if Consultant terminates his engagement pursuant to Section 2(f), the Company shall pay the Consultant, in accordance with its payroll practices, in effect from time to time, his Base Salary for a period of thirty days (30) from the date of resignation regardless of Consultant’s engagement status. None of the provisions of this Agreement shall be construed to affect the Consultant’s rights to a continuation of group health plan benefits, if so provided. 
  
 All payments under this Section 3(a) shall become due and payable without discount or offset. The payments provided for in this Section 3(a), whether or not payable in a particular circumstance, shall be in lieu of all other payments and all other rights to receive payments to which the Consultant may be entitled under this Agreement or under federal or state law and shall constitute a full satisfaction and discharge of any claims by the Consultant related to this Agreement or the circumstances surrounding the termination of his engagement hereunder.
  
  
 	 (b)
	 Upon termination of his engagement, the Consultant shall return to the Company all property previously provided to the Consultant by the Company and all other Company property that is otherwise in the custody, possession or control of the Consultant.

	  
	  

	 (c)
	 Termination of his engagement shall not in any manner release or be construed as releasing any party hereto from any liability to any other party hereto arising out of such party's breach, default or failure in the performance of any of his or its covenants, agreements, duties or obligations under this Agreement.

	  
	  

	 4.
	 Compensation. 

	  
	  

	 (a)
	 Consulting Period Compensation.  During the Consulting Period, the Company shall pay Consultant a monthly fee equal to Twelve Thousand Five Hundred ($12,500) (the “Consulting Compensation”).  The Consultant shall not be entitled to receive any compensation, whether in the form of wages or benefits, other than the Consulting Compensation during the Consulting Period.  The Consultant will be solely responsible for withholding and paying all income taxes, withholding taxes, self-employment taxes, Social Security, and other taxes required by applicable law. As of the Effective Date, the Consultant shall provide the Company with a completed W-9 form. The Company will report all Consulting Compensation paid to the Consultant during the Consulting Period on IRS Form 1099.

	  
	  

	 (b)
	 Participation in Incentive Plans. During the Consultant’s engagement with the Company, the Consultant shall be entitled to participate in all incentive stock option (as provided in this Agreement), savings and retirement plans, policies and programs maintained in force by the Company, including any qualified pension, profit sharing or other retirement plans, non-qualified retirement and deferred compensation plans, and other similar retirement and welfare benefit plans, programs and arrangements, provided that the Consultant qualifies for participation in such plans, programs and arrangements pursuant to the terms thereof.

	  
	  

	  
	  

	 (c)
	 Expense Reimbursement.  The Company shall pay or reimburse the Consultant (or, in the Company’s sole discretion, shall pay directly), upon a proper accounting as the Company may reasonably require, for reasonable business related expenses and disbursements incurred by the Consultant in the course of the performance of the Consultant’s duties under this Agreement, provided that the incurring of such expenses shall have been approved in accordance with the Company’s regular reimbursement procedures and normal policies of the Company in effect from time to time.

 
 
  
 5. Representations of Consultant. The Consultant hereby represents and warrants to the Company that (a) this Agreement is the valid, legal and binding obligation of Consultant, and (b) this Agreement does not, and the Consultant’s performance of his duties hereunder will not, violate any provision of any agreement, indenture or other instrument, or any fiduciary or other obligation, to which the Consultant is a party or by which it is bound.
  
 6. Indemnification. The Company hereby agrees to indemnify and hold harmless Consultant from any and all losses, claims, demands, liabilities and expenses (including reasonable legal or other expenses, including reasonable attorneys’ fees) arising out of, based upon or related to any action taken by Consultant in his capacity as an officer, director or employee of the Company but specifically excluding any action taken by Consultant which is beyond the scope or authority of his capacity as an officer, director or employee of the Company, is a violation of any criminal law or constitutes gross negligence or willful misconduct on Consultant’s part, all in accordance with the Company’s Memorandum of Association and Articles of Incorporation.
  
 7. Intellectual Property Assignment. The Consultant hereby agrees to assign title and all licensing rights and prosecution obligations to the Company, and/or its affiliates or designee, upon the Commencement Date of this Agreement, all intellectual property of which the Consultant may be identified as an inventor/co-inventor which relates to the business of the Company.
  
 8. Restrictive Covenants.  
  
  
 	  
	  

	 (a)
	 During the term of this Agreement, and for the period of twenty-four (24) months after the Consultant no longer is engaged by the Company for any reason, Consultant shall not, either as an individual on his own account or as a shareholder, agent, member, partner, officer, director, manager, employee or independent contractor, directly or indirectly:

 
 
  
  
 	  
	 (i)
	 enter into, conduct, or engage, directly or indirectly invest in, own, manage or operate any entity engaged in or planning to become engaged in the business of the Company (collectively, the “Restricted Business”) within the United States of America (the “Restricted Territory”), either directly or as a principal, partner, member, shareholder, employee, manager, officer, director, advisor or independent contractor of any entity;

	  
	  
	  

	  
	 (ii)
	 own any interest in any entity engaged in the Restricted Business (except as a passive investor owing less than two percent (2%) of the equity securities of a publicly owned company);

	  
	  
	  

	  
	 (iii) 
	 act as a consultant to any entity directly or indirectly engaged in the Restricted Business; 

 
 
  
   
 	  
	 (iv)
	 employ or solicit, receive or attempt to receive the performance of any services by any employee, agent or independent contractor of the Company; 

	  
	  
	  

	  
	 (v)
	 directly or indirectly solicit, encourage or induce any employee of the Company to become an employee of or otherwise provide services to any entity other than the Company or any of its subsidiaries or affiliates, or to terminate his or her engagement with the Company or any of its subsidiaries or affiliates; or

	  
	  
	  

	  
	 (vi)
	 disrupt or interfere with any of the Company’s relationships with any of its vendors or clients.  

 
  
 
  
 	 (b)
	 Confidentiality.  Consultant acknowledges that, upon execution of this Agreement and by reason of his service to the Company, Consultant will have come into possession or will have acquired knowledge of or contribute to the development of confidential information of the Company. This confidential information includes, but is not limited to: this Agreement, internal management procedures and processes, methods and accumulated experience incidental to the business provided by the Company including, without limitation, those internal operating procedures and functions not generally known to the public including the Company’s client lists, prospect lists, its vendors’ lists, its pricing of services lists, its internal operational financial data, trade secrets and market research (the “Confidential Information”).  Consultant shall not use or disclose to others any Confidential Information relating to the Company received from the Company or from any other source for any purpose other than for the benefit of the Company.  The restrictions imposed by this Section shall continue to apply to Consultant, notwithstanding his termination from the Company.  The restrictions on disclosure set forth in this Section shall not apply to any Confidential Information to the extent that such Confidential Information can be shown to have been: (i) generally available to the public other than as a result of a breach of the provisions of this Agreement; (ii) already in the possession of the receiving party, without any restriction on disclosure, prior to any disclosure of such information to the receiving party by or on behalf of the Company or any Member pursuant to the terms of this Agreement or otherwise; (iii) lawfully disclosed, without any restriction on additional disclosure, to the receiving party by a third party who is free lawfully to disclose the same; or (iv) independently developed by the receiving party without use of any such Confidential Information.

	  
	  

	 (c)
	 Scope.  The restrictions and limitations contained in this Section are reasonable as to scope and duration and are necessary in part to protect the Company’s proprietary interest in its Confidential Information and to preserve for the Company the competitive advantage derived from maintaining that information as secret.  In the event that any of the restrictions and limitations contained in this Section are deemed to exceed the time or geographic limitations permitted by applicable law, then such provisions of this Section shall be reformed to the maximum time or maximum geographic limitations permitted by applicable law.

 
 
  
 
   
  	 (d)
	 Breach.  Consultant acknowledges and agree that it is impossible to measure in money the damages which will accrue to the Company if Consultant should breach any of the terms of this Section.  Accordingly, if any action or proceeding is instituted by or on behalf of the Company to enforce any term of this Section, Consultant hereby agrees to waive any claim or defense that the Company has an adequate remedy by law or that the Company has not been nor is not then irreparably harmed as a result of the breach, or the necessity of the posting of any bond. The rights and remedies of the Company pursuant to this Agreement are cumulative, in addition to and shall not be deemed to exclude any other right or remedy which the Company may have pursuant to this Agreement or otherwise, at law or in equity, including, without limitation, the rights and remedies available to the Company under any of the laws of the State of New York.

	  
	  

	 12.
	 General Provisions.

 
  
 (a) Entire Agreement. This Agreement and the Related Agreements contain the entire understanding between the parties hereto and supersedes any prior employment and consulting agreements and understandings between the Company and Consultant.
  
 (b) Non-assignability. Neither this Agreement nor any right or interest hereunder shall be assignable by the Consultant, his heirs, beneficiaries or legal representatives without the Company’s prior written consent provided, however, that nothing in this Section 12 shall preclude:
  
  
 	  
	 (i)
	 The Consultant from designating a beneficiary to receive benefits payable hereunder upon his death; or

	  
	  
	  

	  
	 (ii)
	 the personal representatives, administrators, or other legal representatives of Consultant or his estate from assigning any rights hereunder to the person or persons entitled to such benefits.

 
 
  
 The Company may assign this Agreement and its rights and interest hereunder without notice to or the consent of the Consultant.
  
 (c) No Attachment. Except as required by law, no right to receive payments under this Agreement shall be subject to anticipation, alienation, sale, assignment, encumbrance, charge, pledge, or hypothecation or to execution, attachment, levy, or similar process or assignment by operation of law, and any attempt, voluntary or involuntary, to effect any such action shall be null, void, and of no effect.
  
 (d) Notice. Any notice, consent, approval or other communication given pursuant to the provisions of this Agreement shall be in writing and shall be (i) delivered by hand, (ii) mailed by certified mail or registered mail, return receipt requested, postage prepaid, or (iii) delivered by a nationally recognized overnight courier, U.S. Post Office Express Mail, or similar overnight courier which delivers only upon signed receipt of the addressee, and addressed as follows:
  
  
 	 
	4
	

	 

 
 
 
  
    
  
 	 If to the Company:
	 AGENTIX Biopharma Corp.
	  
	  

	  
	  
	  
	  

	  
	  
	  
	  

	 Attention:
	  
	  
	  

	  
	  
	  
	  

	 If to the Consultant:
	 Salman Hoda Pharma Consulting Inc.
	  
	  

	  
	  
	  
	  

	  
	  
	  
	  

	  
	 Email: ___________________
	  
	  

	  
	  
	  
	  

	  
	  
	  
	  

 
 
  
 Any notice shall be effective as of the time of receipt thereof by the addressee or any agent of the addressee, except that in the event the addressee or such agent of the addressee shall refuse to receive any notice given by registered mail or certified mail as above provided or there shall be no person available at the time of the delivery thereof to receive such notice, the time of the giving of such notice shall be the time of such refusal or the time of such delivery, as the case may be. Any party hereto may, by giving five (5) days written notice to the other party hereto in the manner described herein, designate any other address in substitution of the foregoing address to which notice shall be given.
  
 (e) Modification. This Agreement may not be modified or amended except by an instrument in writing signed by the party against whom enforcement is sought.
  
 (g) Waiver. No term or condition of this Agreement shall be deemed to have been waived, nor shall there be any estoppel against the enforcement of any provision of this Agreement, except by written instrument of the party charged with such waiver or estoppel. No such written waiver shall be deemed a continuing waiver unless specifically stated therein, and each such waiver shalloperate only as to the specific term or condition waived and shall not constitute a waiver of such term or condition for the future or as to any act other than that specifically waived.
  
  
 (g) Governing Law. The validity, construction, enforcement of and the remedies under this Agreement shall be governed in accordance with the laws of New York, without regard to its choice of law provisions.
  
 (h) Headings. The section headings used herein are included solely for convenience of reference and shall not control the meaning or interpretation of any of the provisions of this Agreement.
  
 (i) Binding Agreement. This Agreement shall be binding upon, and inure to the benefit of, the Consultant and the Company, and the Company’s successors and assigns. The rights and obligations hereunder are also being granted for the benefit of any subsidiaries of the Company, and such rights and obligations may be enforced by a subsidiary of the Company.
  
 (j) Additional Acts. The Consultant and the Company each agrees to execute, acknowledge and deliver all further instruments, agreements or documents and do all further acts that are necessary or expedient to carry out this Agreement’s intended purposes. Without limiting the generality of the foregoing, Consultant will enter into a stockholder’s agreement implementing the foregoing vesting arrangements and covering voting and restrictions on transfer of the Restricted Shares or Stock Options and will enter into the Company’s standard form of intellectual property rights assignment agreement.
  
  
 	 
	5
	

	 

 
 
  
 (k) Construction. Each of the parties hereto declare that they or their counsel participated in the drafting of this Agreement and that, accordingly, this Agreement shall not be construed more strongly against any party hereto because it drafted this Agreement.
  
 (l) Severability. The invalidity or unenforceability of any one or more of the validity or enforceability of the remaining provisions of this Agreement or any part of any provision, all of which are inserted conditionally on their being valid in law, and in the event that any one or more of the words, phrases, sentences, clauses or sections contained in this Agreement shall be declared invalid or unenforceable, this Agreement shall be construed as if such invalid or unenforceable word or words, phrase or phrases, sentence or sentences, clause or clauses, or section or sections had not been inserted or shall be enforced as nearly as possible according to their original terms and intent to eliminate any invalidity or unenforceability. If any invalidity or unenforceability is caused by the length of any period of time or the size of any area set forth in any part of this Agreement, the period of time or area, or both, shall be considered to be reduced to a period or area which would cure the invalidity or unenforceability.
  
 (m) Remedies. Unless otherwise specified herein, no remedy conferred upon either party to this Agreement is intended to be exclusive of any other remedy herein or by law provided or permitted, but each shall be cumulative and shall be in addition to every other remedy given hereunder or now or hereafter existing at law or in equity. Every power or remedy given by this Agreement to any party or to which such party may otherwise be entitled, may be exercised concurrently or independently, from time to time, and as often as may be deemed expedient and inconsistent remedies may be pursued. Because a breach of the provisions of this Agreement will not adequately be compensated by money damages, the Company shall be entitled, in addition to any other right or remedy available, to an injunction restraining such breach or a threatened breach and to specific performance of any such provision of this Agreement and in either case no bond or other security shall be required in connection therewith, and the parties hereby consent to the issuance of such injunction and to the ordering of specific performance.
  
 (n) Enforcement. If any party hereto shall fail to perform any covenant or condition hereof or shall otherwise be in breach of this Agreement, such party shall pay to the non-defaulting party its reasonable attorneys’ fees and costs incurred as a result of their efforts to enforce this Agreement (whether or not litigation is commenced, at all trial and appellate levels and in bankruptcy).
  
 (o) Forum Selection: THE PARTIES HERETO EXPRESSLY SUBMIT THEMSELVES TO AND AGREE THAT ALL ACTIONS ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE RELATIONSHIP BETWEEN THE PARTIES HERETO SHALL OCCUR SOLELY IN THE VENUE AND JURISDICTION OF NEW YORK.
  
 	 
	6
	

	 

 
 
  
 (p) Dispute Resolution. All disputes, claims and controversies arising from this Agreement, including without limitation, all disputes regarding the construction, validity, interpretation, enforceability or breach of the terms hereof, shall be exclusively resolved through binding arbitration to be administered by one arbitrator in New York in accordance with the rules of the American Arbitration Association. Judgment upon any award made by the arbitrator shall be final and binding upon the parties, and may be entered in any Court of competent jurisdiction located in New York. Except as otherwise provided in this Agreement, arbitration shall be the sole, exclusive and final remedy with respect to all disputes arising from this Agreement. The prevailing party shall be entitled to recover all reasonable attorneys’ fees and costs incurred in connection with the arbitration proceedings.
  
 (q) Execution in Counterpart. The parties hereto may execute this Agreement in two or more counterparts, each of which shall be deemed to be an original, but all such counterparts shall constitute one and the same instrument, and all signatures need not appear on any one counterpart.
  
 [signature page follows]
  
  
 	 
	7
	

	 

 
 
  
 IN WITNESS WHEREOF, the parties hereto have executed and delivered this Agreement as of the day and year first above written.
  
  
 	 AGENTIX Biopharma Corp:
	 
	 
	 Salman Hoda Pharma Consulting Inc.:

	 
	 
	 
	 

	 /s/ Rudy A. Mazzocchi
	 
	 
	 /s/ Salman Hoda

	 Name: Rudy A. Mazzocchi
	 
	 
	 Name: Salman Hoda

	 Title: Chief Executive Officer
	 
	 
	 Title: Chief Executive Officer

 
 
 
  
 [signature page to consulting and consulting agreement]
  
  
 	 
	8
	

	 

 
 
 SCHEDULE A
  
 Independent Contracting Services
  
 Management of the following development programs:
  
  
 	 -
	 Consumer Healthcare Products in partnership with BIONOVA LAB.

	  
	  

	 -
	 Pharmaceutical Programs

 
  
 
  
 	  
	 o
	 Identifying and securing development and commercialization partners for programs targeting LGDS and CINV

	  
	  
	  

	  
	 o
	 Providing assistance with the development and commercialization of VOCAN Brazil

	  
	  
	  

	  
	 o
	 Providing assistance with AGENTIX’s other pharma programs where requested

 
 
  
 Investor relations:
  
  
 	 -
	 Assisting in the development of investor slide decks

	  
	  

	 -
	 Participating in investor calls and answering questions

	  
	  

	 -
	 Providing assistance in other activities where requested

 
  
 
  
 	 
	9

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]